Description
BSE notifies trading members that four SBI Fixed Maturity Plan (FMP) Series 68 schemes will mature and trading will be suspended effective April 13, 2026.
Summary
BSE has issued a notice (Notice No. 20260410-4) informing trading members that four schemes under SBI Fixed Maturity Plan (FMP) Series 68 (1302 Days) will mature on their respective Redemption Dates. Trading in all four schemes will be suspended effective April 13, 2026.
Key Points
- Four SBI FMP Series 68 (1302 Days) schemes are maturing and will be suspended from trading on BSE from April 13, 2026.
- The affected schemes cover both Regular and Direct Plans, under Growth and IDCW Payout options.
- Trading members are advised not to deal in any of the four affected scrips from the effective date.
- Reference number for this action: DR-609/2026-2027.
Regulatory Changes
No new regulatory changes introduced. This is a standard operational notice for the scheduled maturity and consequent delisting/suspension of fixed maturity plan units from exchange trading.
Compliance Requirements
- Trading members must cease all transactions in the four listed scrip codes (543609, 543610, 543611, 543612) with effect from April 13, 2026.
- Members should ensure no buy or sell orders are placed for these schemes on or after the suspension date.
Important Dates
- Notice Date: April 10, 2026
- Trading Suspension Effective Date: April 13, 2026 (Redemption/Maturity Date)
Impact Assessment
This suspension affects investors holding units of SBI FMP Series 68 (1302 Days) in any of the four variants on BSE. As these are closed-ended fixed maturity plans reaching their scheduled maturity, the impact is limited and expected. Unitholders will receive redemption proceeds as per the scheme terms. The broader market impact is minimal as these are specific closed-ended debt mutual fund schemes.
Impact Justification
Routine maturity-driven trading suspension affecting four SBI FMP Series 68 schemes; impacts only holders of these specific closed-ended mutual fund units listed on BSE.